Administration of Cetuximab and IL-15 superagonist N-803 (formerly ALT-803) in mice harboring Cal27 squamous cell carcinoma of head and neck tumors significantly decreased tumor volume when compared to controls and single-agents treatment alone (38). This evidence concerns the gene IL15 and head and neck neoplasm.